Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel - Sorbonne Université
Article Dans Une Revue JACC: Cardiovascular Interventions Année : 2020

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score.

Dominick Angiolillo
  • Fonction : Auteur
Davide Capodanno
  • Fonction : Auteur
Nicolas Danchin
  • Fonction : Auteur
Tabassome Simon
Thomas Bergmeijer
  • Fonction : Auteur
Jurrien ten Berg
  • Fonction : Auteur
Dirk Sibbing
Matthew Price
  • Fonction : Auteur

Résumé

The aim of this study was to develop a risk score integrating cytochrome P450 2C19 loss-of-function genotypes with clinical risk factors influencing clopidogrel response that would allow the identification with more precision of subjects at risk for high platelet reactivity (HPR) and adverse clinical outcomes.

Dates et versions

hal-03030882 , version 1 (30-11-2020)

Identifiants

Citer

Dominick Angiolillo, Davide Capodanno, Nicolas Danchin, Tabassome Simon, Thomas Bergmeijer, et al.. Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel. JACC: Cardiovascular Interventions, 2020, 13 (5), pp.606-617. ⟨10.1016/j.jcin.2020.01.226⟩. ⟨hal-03030882⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

More